RECRUITING

Opioid Sparing Effect of an ISP Nerve Block on Post-Op Pain Control in Posterior Cervical Spine Surgery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Participants who have a surgical procedure called Posterior Cervical (neck) Spine Surgery will normally need pain medication to relieve post operative pain. This usually includes opioid medications. In this study, the consented participant may receive a nerve block procedure, in addition to the pain relieving medication. There is a fifty-fifty chance to receive the nerve block. The goal is to see if the nerve block group needs less opioid medication, has lower pain scores and is discharged from the hospital sooner.

Official Title

The Opioid Sparing Effect of an Inter-semispinalis Plane Block on Postoperative Pain Control in Posterior Cervical Spine Surgery

Quick Facts

Study Start:2025-02-21
Study Completion:2026-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06570577

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Having Posterior Cervical Spine Surgery from C2 - C7, which may extend to the upper thoracic vertebrae, inclusive to T3.
  2. * Capacity to provide informed consent
  1. * Fusion and decompression due to trauma
  2. * Emergent procedures
  3. * Patient is on a medication-assisted treatment, e.g., buprenorphine, naltrexone or methadone.
  4. * There is an infection near or in the area of neck where the block will be placed.
  5. * The patient is having a complicated surgery or a revision surgery
  6. * Female patient with a positive pregnancy test on the day of surgery (hospital standard-of-care).
  7. * Patient has Diabetes
  8. * Patients who have had a prior adverse reaction to bupivacaine or dexamethasone
  9. * Patients with Glucose-6-phosphate dehydrogenase deficiency or congenital or idiopathic methemoglobinemia

Contacts and Locations

Study Contact

Eman Nada, MBBCH
CONTACT
516-287-9118
Eman.Nada@stonybrookmedicine.edu
Darcy Halper, B.S.
CONTACT
631-444-2970
Darcy.Halper@stonybrookmedicine.edu

Principal Investigator

Eman Nada, MBBCH
PRINCIPAL_INVESTIGATOR
Stony Brook University Hospital

Study Locations (Sites)

Stony Brook University Hospital
Stony Brook, New York, 11794
United States

Collaborators and Investigators

Sponsor: Stony Brook University

  • Eman Nada, MBBCH, PRINCIPAL_INVESTIGATOR, Stony Brook University Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-21
Study Completion Date2026-02

Study Record Updates

Study Start Date2025-02-21
Study Completion Date2026-02

Terms related to this study

Keywords Provided by Researchers

  • cervical fusion
  • opioids

Additional Relevant MeSH Terms

  • Pain, Postoperative